In esophageal diseases, Vasavi et al. found MLH1 promoter hypermethylation in 88.8% of GERD patients, compared to 63.5% in EAC and 53.8% in BE, as determined by a restriction enzyme–based methylation assay. This evidence concerns the gene MLH1 and Barrett esophagus.